Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma (vol 40, pg 1125, 2022)

被引：0

作者：

Yuan, Peng ^{[1
]}

Song, Jinhua ^{[2
]}

Wang, Fei ^{[1
]}

Zhu, Guangyu ^{[3
]}

Chen, Baoan ^{[1
]}

机构：

[1] Southeast Univ, Zhongda Hosp, Med Sch, Dept Hematol & Oncol,Key Discipline Jiangsu Med, Nanjing 210009, Jiangsu, Peoples R China

[2] Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Ctr, Nanjing 210029, Jiangsu, Peoples R China

[3] Southeast Univ, Zhongda Hosp, Med Sch, Dept Intervent Radiol, Nanjing 210009, Jiangsu, Peoples R China

来源：

关键词：

D O I：

10.1007/s10637-022-01323-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：182 / 182

页数：1

共 3 条